AstraZeneca: "In Oncology, Research Focuses on Increasingly Early and Personalized Care"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
"To act first and foremost against cancer, to develop new combinations of drugs and to strengthen precision medicine. These are some of the guidelines on which cancer research is moving, as emerges from the data presented at Esmo in Madrid. This congress is an important moment. The four studies presented in the plenary sessions reflect the direction that is taking oncology: to intervene earlier, to exploit the potential of combinations and to re…
"To act first and foremost against cancer, to develop new combinations of drugs and to strengthen precision medicine. These are some of the guidelines on which cancer research is moving, as emerges from the data presented at Madrid's Esmo. This congress is an important moment. The four studies presented in the plenary sessions reflect the direction that is taking place... Continue readingThe articlePanella (AstraZeneca): "In oncology, research f…
Rec News | Lontani dal mainstream
notizie.it"To act first and foremost against cancer, to develop new combinations of drugs and to strengthen precision medicine. These are some of the guidelines on which cancer research is moving, as emerges from the data presented at Madrid's Esmo. This congress represents an important moment. The four studies presented in the plenary sessions reflect the direction [...] The article Delicateness (AstraZeneca): "In oncology research focuses on increasingl…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
